Organ Failure, Endotoxin Activity, and Mortality in Septic Shock
ESS compromises patients with the highest mortality rate from sepsis. Such patients are most appropriate for trials testing anti-endotoxin therapy for improving survival.
Authors
- Mark Tidswell (ORCID: https://orcid.org/0000-0001-6333-6810)
- John A. Kellum (ORCID: https://orcid.org/0000-0003-1995-2653)
- Luca Molinari (ORCID: https://orcid.org/0000-0002-7372-4953)
- Claude Galphin
- Ali Al‐Khafaji (ORCID: https://orcid.org/0000-0002-3441-3917)
- Danielle Davison (ORCID: https://orcid.org/0000-0001-8535-7145)
- Debra Foster
- Esha Kamaluddin
Institutions
- Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
- Baystate Medical Center (US)
- University of Pittsburgh (US)
- George Washington University (US)
- Southeast Renal Research Institute (US)
- Iridian Spectral Technologies (Canada) (CA)
Publication Details
- Journal
- Critical Care Explorations
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1097/cce.0000000000001308
- Citations
- 2
- Primary Topic
- Sepsis Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.71